Precisely Fabricated Sulpiride-Loaded Nanolipospheres with Ameliorated Oral Bioavailability and Antidepressant Activity

生物利用度 药理学 舒必利 药代动力学 化学 口服 渗透 药品 药效学 离体 色谱法 医学 生物化学 体外 敌手 受体
作者
Salma M. Mohyeldin,Wael Samy,Doaa Ragab,Doaa A. Abdelmonsif,Rania G. Aly,Nazik A. Elgindy
出处
期刊:International Journal of Nanomedicine [Dove Medical Press]
卷期号:Volume 16: 2013-2044 被引量:5
标识
DOI:10.2147/ijn.s296726
摘要

Sulpiride (SUL), is a selective antidopaminergic drug that had extensive biological activities. However, its sparingly aqueous solubility and limited gastrointestinal permeability lead to scanty oral bioavailability which hinders its clinical efficacy.SUL-loaded lipospheres (SUL-LPS) were designed to serve as an oral biocompatible nanovector for improving SUL permeability as well as conquering its low oral absorption and then in turn enhancing its antidepressant action.SUL-LPS were fabricated via two processing techniques namely, melt emulsification and solvent evaporation. The impact of different lipid cores, phospholipid shells together with various surfactant concentrations and types on the lipospheres properties were screened. Detailed physicochemical elucidations were performed followed by ex vivo permeation appraisal using the non-everted intestine model. The pharmacokinetic parameters of SUL-LPS, free SUL and marketed product were assessed following oral administration to healthy rats. Reserpine-induced depression rat model was used to assess the antidepressant action of SUL-LPS on which full behavioural and biochemical analysis was conducted. Safety attributes of nanoencapsulated SUL on the brain and other internal organs were evaluated.The optimum LPS revealed an excellent nanosize with a narrow PdI, negative zeta potential and acceptable entrapment efficiency of 68.62 nm, 0.242, -30.4 mV and 84.12%, respectively. SUL-LPS showed a sustained release pattern and 2.1-fold enhancement in the intestinal permeation parameters with low mucin interaction. Oral pharmacokinetic appraisal exhibited that LPS provided 3.4-fold improvement in SUL oral bioavailability together with long-circulating properties, relative to the free drug. Pharmacodynamic study confirmed the superior antidepressant action of SUL-LPS as evident by 1.6 and 1.25-fold elevation in the serotonin and dopamine expressions, respectively. Meanwhile, nanotoxicological appraisal proved the biocompatibility of SUL-LPS upon repetitive oral administration.Rationally designed lipospheres hold promising in vitro and in vivo characteristics for efficient delivery of SUL with high oral bioavailability, antidepressant activity together with a good safety profile.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吾猫发布了新的文献求助10
刚刚
mmmmm完成签到,获得积分10
刚刚
爆米花应助韩无忧采纳,获得10
刚刚
1秒前
1秒前
巴拉巴拉发布了新的文献求助10
2秒前
zxj发布了新的文献求助10
3秒前
3秒前
4秒前
7秒前
8秒前
hwl26发布了新的文献求助10
8秒前
9秒前
9秒前
朴实初夏完成签到 ,获得积分10
9秒前
闪闪溪灵发布了新的文献求助10
9秒前
大模型应助领奖采纳,获得10
10秒前
YYL完成签到,获得积分10
10秒前
卡萨卡萨完成签到,获得积分10
11秒前
12秒前
徐慕源发布了新的文献求助30
12秒前
void科学家发布了新的文献求助10
14秒前
14秒前
16秒前
852应助云鲲采纳,获得10
17秒前
zzzzz完成签到,获得积分10
17秒前
大个应助BohanHou采纳,获得10
17秒前
18秒前
18秒前
xiaodan应助jiejie采纳,获得10
20秒前
杨。。完成签到 ,获得积分10
20秒前
21秒前
21秒前
小秦同学发布了新的文献求助10
22秒前
blush完成签到 ,获得积分10
22秒前
QY发布了新的文献求助10
23秒前
void科学家完成签到,获得积分10
23秒前
keyan发布了新的文献求助10
25秒前
汪小白发布了新的文献求助10
25秒前
orixero应助s211998采纳,获得10
26秒前
高分求助中
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 800
Becoming: An Introduction to Jung's Concept of Individuation 600
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
Blattodea, Mantodea, Isoptera, Grylloblattodea, Phasmatodea, Dermaptera and Embioptera, Volume 3, Part 2 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3165832
求助须知:如何正确求助?哪些是违规求助? 2817091
关于积分的说明 7914877
捐赠科研通 2476611
什么是DOI,文献DOI怎么找? 1319056
科研通“疑难数据库(出版商)”最低求助积分说明 632332
版权声明 602415